Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer.

Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer. Am J Clin Oncol. 1996 Dec; 19(6):592-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.